false 0000073290 0000073290 2024-12-13 2024-12-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 13, 2024

 

BIOMERICA, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37863   95-2645573

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

17571 Von Karman Ave. Irvine, California   92614
(Address of Principal Executive Offices)   (Zip Code)

 

(949) 645-2111

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $.08   BMRA   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

Biomerica, Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) on December 13, 2024, at its corporate headquarters in Irvine, California. As of October 16, 2024, the record date for the 2024 Annual Meeting, the Company had 16,821,646 shares of common stock outstanding and entitled to vote, of which 10,287,675 shares of common stock were present in person or represented by proxy and entitled to vote at the 2024 Annual Meeting. The following is a brief description of the final voting results for each of the proposals submitted to a vote of the stockholders at the 2024 Annual Meeting.

 

Proposal No. 1: The Company’s stockholders elected each of the five nominees named below to serve on the Company’s Board of Directors (the “Board”) until the next annual meeting of stockholders of the Company and until his or her successor has been elected and qualified or until his or her earlier resignation, death or removal.

 

Nominee  Votes For   Votes Withheld   Broker Non-votes 
Zackary Irani   4,784,611    169,339    5,524,703 
Allen Barbieri   4,757,823    196,127    5,524,703 
Jane Emerson, M.D., Ph.D.   4,611,714    342,236    5,524,703 
Catherine Coste   4,779,659    174,291    5,524,703 
David Moatazedi   4,772,930    181,020    5,524,703 

 

Proposal No. 2: The Company’s stockholders approved, on a non-binding advisory basis, the compensation paid to our named executive officers.

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes 
 4,613,080    275,661    65,209    5,524,703 

 

Proposal No. 3: The Company’s stockholders ratified the selection of Haskell & White LLP as the Company’s independent registered public accounting firm for the fiscal year ending May 31, 2025.

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes 
 10,287,675    94,547    96,431    — 

 

Proposal No. 4: The Company’s stockholders approved the 2024 Stock Incentive Plan.

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes 
 4,186,308    730,217    37,425    5,524,703 

 

Proposal No. 5: The Company’s stockholders approved the amendment to the Company’s First Amended and Restated Certificate of Incorporation to authorize the Board, at their discretion, to effect a reverse stock split of the Company’s common stock.

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes 
 9,789,531    558,553    130,569    — 

 

Proposal No. 6: The Company’s stockholders approved the amendment to the Company’s First Amended and Restated Certificate of Incorporation to authorize the Board, at their discretion, to effect an increase in the number of authorized shares of the Company’s common stock.

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes 
 9,619,013    770,675    88,965    — 

 

Proposal No. 7: The Company’s stockholders approved an adjournment of the Annual Meeting, if necessary or appropriate, including to establish a quorum.

 

Votes For   Votes Against   Votes Abstaining   Broker Non-Votes 
 9,905,692    360,840    212,121    — 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BIOMERICA, INC.
     
Date: December 17, 2024 By: /s/ Zackary S. Irani
    Zackary S. Irani
    Chief Executive Officer

 

 

v3.24.4
Cover
Dec. 13, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 13, 2024
Entity File Number 001-37863
Entity Registrant Name BIOMERICA, INC.
Entity Central Index Key 0000073290
Entity Tax Identification Number 95-2645573
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 17571 Von Karman Ave.
Entity Address, City or Town Irvine
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92614
City Area Code (949)
Local Phone Number 645-2111
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $.08
Trading Symbol BMRA
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Biomerica (NASDAQ:BMRA)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Biomerica.
Biomerica (NASDAQ:BMRA)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Biomerica.